280 related articles for article (PubMed ID: 31545468)
1. Exploring the active mechanism of berberine against HCC by systematic pharmacology and experimental validation.
Song L; Luo Y; Wang X; Almutairi MM; Pan H; Li W; Liu Y; Wang Q; Hong M
Mol Med Rep; 2019 Nov; 20(5):4654-4664. PubMed ID: 31545468
[TBL] [Abstract][Full Text] [Related]
2. Berberine Suppresses EMT in Liver and Gastric Carcinoma Cells through Combination with TGF
Du H; Gu J; Peng Q; Wang X; Liu L; Shu X; He Q; Tan Y
Oxid Med Cell Longev; 2021; 2021():2337818. PubMed ID: 34712379
[TBL] [Abstract][Full Text] [Related]
3. Berberine induces selective apoptosis through the AMPK‑mediated mitochondrial/caspase pathway in hepatocellular carcinoma.
Yang X; Huang N
Mol Med Rep; 2013 Aug; 8(2):505-10. PubMed ID: 23732865
[TBL] [Abstract][Full Text] [Related]
4. Berberine Targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and Cytochrome-c/Caspase Signaling to Suppress Human Cancer Cell Growth.
Fu L; Chen W; Guo W; Wang J; Tian Y; Shi D; Zhang X; Qiu H; Xiao X; Kang T; Huang W; Wang S; Deng W
PLoS One; 2013; 8(7):e69240. PubMed ID: 23869238
[TBL] [Abstract][Full Text] [Related]
5. Berberine exerts its antineoplastic effects by reversing the Warburg effect via downregulation of the Akt/mTOR/GLUT1 signaling pathway.
Guo XH; Jiang SS; Zhang LL; Hu J; Edelbek D; Feng YQ; Yang ZX; Hu PC; Zhong H; Yang GH; Yang F
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34643248
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Akt/FoxO3a/Skp2 Axis Is Critically Involved in Berberine-Induced Cell Cycle Arrest in Hepatocellular Carcinoma Cells.
Li F; Dong X; Lin P; Jiang J
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29360760
[TBL] [Abstract][Full Text] [Related]
7. Berberine induces apoptosis by suppressing the arachidonic acid metabolic pathway in hepatocellular carcinoma.
Li J; Li O; Kan M; Zhang M; Shao D; Pan Y; Zheng H; Zhang X; Chen L; Liu S
Mol Med Rep; 2015 Sep; 12(3):4572-4577. PubMed ID: 26081696
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Anticancer Activity of 9-O-Pyrazole Alkyl Substituted Berberine Derivatives.
Xiao D; He F; Peng D; Zou M; Peng J; Liu P; Liu Y; Liu Z
Anticancer Agents Med Chem; 2018; 18(11):1639-1648. PubMed ID: 30014806
[TBL] [Abstract][Full Text] [Related]
9. Berberine increases the killing effect of pirarubicin on HCC cells by inhibiting ATG4B-autophagy pathway.
He H; He M; Wang Y; Xiong H; Xiong Y; Shan M; Liu D; Guo Z; Kou Y; Zhang Y; Yang M; Lian J; Sun L; He F
Exp Cell Res; 2024 Jun; 439(1):114094. PubMed ID: 38750718
[TBL] [Abstract][Full Text] [Related]
10. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
[TBL] [Abstract][Full Text] [Related]
11. Berberine inhibits IL-21/IL-21R mediated inflammatory proliferation of fibroblast-like synoviocytes through the attenuation of PI3K/Akt signaling pathway and ameliorates IL-21 mediated osteoclastogenesis.
Dinesh P; Rasool M
Cytokine; 2018 Jun; 106():54-66. PubMed ID: 29549724
[TBL] [Abstract][Full Text] [Related]
12. Exploring the synergistic and complementary effects of berberine and paeoniflorin in the treatment of type 2 diabetes mellitus by network pharmacology.
Zhang L; Han L; Ma J; Wu T; Wei Y; Zhao L; Tong X
Eur J Pharmacol; 2022 Mar; 919():174769. PubMed ID: 35151646
[TBL] [Abstract][Full Text] [Related]
13. Berberine Represses
Vishnoi K; Ke R; Saini KS; Viswakarma N; Nair RS; Das S; Chen Z; Rana A; Rana B
Mol Pharmacol; 2021 Jan; 99(1):1-16. PubMed ID: 33130557
[TBL] [Abstract][Full Text] [Related]
14. Comparison of anti-inflammatory effects of berberine, and its natural oxidative and reduced derivatives from Rhizoma Coptidis in vitro and in vivo.
Li CL; Tan LH; Wang YF; Luo CD; Chen HB; Lu Q; Li YC; Yang XB; Chen JN; Liu YH; Xie JH; Su ZR
Phytomedicine; 2019 Jan; 52():272-283. PubMed ID: 30599908
[TBL] [Abstract][Full Text] [Related]
15. Coptidis rhizoma extract alleviates oropharyngeal candidiasis by gC1qR-EGFR/ERK/c-fos axis-induced endocytosis of oral epithelial cells.
Bao M; Bu Q; Pan M; Xu R; Chen Y; Yang Y; Wang C; Wang T
J Ethnopharmacol; 2024 Sep; 331():118305. PubMed ID: 38729536
[TBL] [Abstract][Full Text] [Related]
16. Computational and experimental prediction of molecules involved in the anti-melanoma action of berberine.
Liu B; Fu XQ; Li T; Su T; Guo H; Zhu PL; Tse AK; Liu SM; Yu ZL
J Ethnopharmacol; 2017 Aug; 208():225-235. PubMed ID: 28729227
[TBL] [Abstract][Full Text] [Related]
17. Induction of Apoptosis by Berberine in Hepatocellular Carcinoma HepG2 Cells via Downregulation of NF-κB.
Li M; Zhang M; Zhang ZL; Liu N; Han XY; Liu QC; Deng WJ; Liao CX
Oncol Res; 2017 Jan; 25(2):233-239. PubMed ID: 28277195
[TBL] [Abstract][Full Text] [Related]
18. Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells.
Zhou Y; Cao S; Wang Y; Xu P; Yan J; Bin W; Qiu F; Kang N
Fitoterapia; 2014 Jan; 92():230-7. PubMed ID: 24321576
[TBL] [Abstract][Full Text] [Related]
19. Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells.
Liu L; Fan J; Ai G; Liu J; Luo N; Li C; Cheng Z
Biol Res; 2019 Jul; 52(1):37. PubMed ID: 31319879
[TBL] [Abstract][Full Text] [Related]
20. In silico network pharmacology and in vivo analysis of berberine-related mechanisms against type 2 diabetes mellitus and its complications.
Di S; Han L; An X; Kong R; Gao Z; Yang Y; Wang X; Zhang P; Ding Q; Wu H; Wang H; Zhao L; Tong X
J Ethnopharmacol; 2021 Aug; 276():114180. PubMed ID: 33957209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]